BMRN vs SAIL · P/E 40, rev $1.76B vs rev $1.07B
Biomarin Pharmaceutical Inc (BMRN) versus SailPoint, Inc. Common Stock (SAIL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
SailPoint, Inc. Common Stock (SAIL) is a software - infrastructure company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SAIL revenue for 2026-01-31 was $1.07B. Net income was -$270.1M. Revenue was up 24.4% from 2025-01-31 to 2026-01-31. SAIL currently screens at market cap $8.06B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SAIL currently screens at market cap $8.06B.
Not investment advice. Open the BMRN and SAIL stock pages for the full models.
Not investment advice.